Volume 30, Number 11—November 2024
Research
Estimating Influenza Illnesses Averted by Year-Round and Seasonal Campaign Vaccination for Young Children, Kenya
Table 2
Vaccination strategy | Prevented fraction | Hospitalizations averted | Outpatient visits averted | Medically attended illnesses averted | Total illnesses averted |
---|---|---|---|---|---|
Year-round vaccination, April start |
13.2
(10.9–15.7) |
349
(286–416) |
3,101
(2,456–3,846) |
3,450
(2,751–4,251) |
7,202
(5,898–8,616) |
Year-round vaccination, October start |
11.7
(9.6–13.9) |
311
(254–371) |
2,754
(2,173–3,414) |
3,066
(2,431–3,769) |
6,410
(5,218–7,692) |
Seasonal campaign vaccination, Apr–Jul |
21.2
(16.9–26.3) |
562
(448–695) |
4,988
(3,828–6,391) |
5,546
(4,287–7,090) |
11,612
(9,220–14,478) |
Seasonal campaign vaccination, Oct–Jan | 18.7 (14.9–23.3) | 497 (394–621) | 4,399 (3,377–5,684) | 4,894 (3,787–6,286) | 10,236 (8,082–12,837) |
*Values are estimated no. (95% CI) except for prevented fraction, which was defined as the number of illnesses averted by vaccination divided by the number of illnesses in the absence of vaccine.
Page created: October 07, 2024
Page updated: October 22, 2024
Page reviewed: October 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.